Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6GZV

Identification of a druggable VP1-VP3 interprotomer pocket in the capsid of enteroviruses

Summary for 6GZV
Entry DOI10.2210/pdb6gzv/pdb
EMDB information0103
DescriptorCapsid protein VP1, Capsid protein VP2, Capsid protein VP3, ... (5 entities in total)
Functional Keywordsinhibitor, complex, virus
Biological sourceCoxsackievirus B3 (strain Nancy)
More
Total number of polymer chains4
Total formula weight94674.45
Authors
Geraets, J.A.,Flatt, J.W.,Domanska, A.,Butcher, S.J. (deposition date: 2018-07-05, release date: 2019-06-05, Last modification date: 2024-05-15)
Primary citationAbdelnabi, R.,Geraets, J.A.,Ma, Y.,Mirabelli, C.,Flatt, J.W.,Domanska, A.,Delang, L.,Jochmans, D.,Kumar, T.A.,Jayaprakash, V.,Sinha, B.N.,Leyssen, P.,Butcher, S.J.,Neyts, J.
A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses.
Plos Biol., 17:e3000281-e3000281, 2019
Cited by
PubMed Abstract: Rhino- and enteroviruses are important human pathogens, against which no antivirals are available. The best-studied inhibitors are "capsid binders" that fit in a hydrophobic pocket of the viral capsid. Employing a new class of entero-/rhinovirus inhibitors and by means of cryo-electron microscopy (EM), followed by resistance selection and reverse genetics, we discovered a hitherto unknown druggable pocket that is formed by viral proteins VP1 and VP3 and that is conserved across entero-/rhinovirus species. We propose that these inhibitors stabilize a key region of the virion, thereby preventing the conformational expansion needed for viral RNA release. A medicinal chemistry effort resulted in the identification of analogues targeting this pocket with broad-spectrum activity against Coxsackieviruses B (CVBs) and compounds with activity against enteroviruses (EV) of groups C and D, and even rhinoviruses (RV). Our findings provide novel insights in the biology of the entry of entero-/rhinoviruses and open new avenues for the design of broad-spectrum antivirals against these pathogens.
PubMed: 31185007
DOI: 10.1371/journal.pbio.3000281
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (4 Å)
Structure validation

239492

PDB entries from 2025-07-30

PDB statisticsPDBj update infoContact PDBjnumon